Tuberculosis Market Research Reports & Industry Analysis
The Mantoux test is used in the United States and is endorsed by the American Thoracic Society and Centers for Disease Control and Prevention (CDC). Multiple puncture tests such as the Tine test are not recommended. The Mantoux test is one of the two major tuberculin skin tests for tuberculosis used in the world.
As a replacement for the Mantoux test, several other tests are being developed. QuantiFERON®-TB Gold, manufactured by Cellestis Limited (Carnegie, Victoria, Australia) is a blood test that measures the patient’s immune reactivity to the M. tuberculosis and is useful for initial and serial testing of persons with an increased risk of latent or active tuberculosis infection. Guidelines for the use of QuantiFERON-®TB Gold were released by the CDC in December of 2005. QuantiFERON®-TB Gold is FDA approved in the United States; has CE Mark approval in Europe; and has been approved by the MHLW in Japan. Sputum smears and cultures should be done for acid-fast bacilli if the patient is producing sputum. The preferred method for this is fluorescence microscopy (auramine-rhodamine staining), which is more sensitive than conventional Ziehl- Neelsen staining.
Tuberculosis Industry Research & Market Reports
-
Tuberculosis (TB) Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... at USD 2.17 billion in 2023, and the market is now projected to grow from USD 2.28 billion in 2024 to USD 3.58 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period ... Read More
-
Global Tuberculosis (TB) Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, ... Read More
-
Pulmonary Tuberculosis - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Pulmonary Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Analysis and Forecast 2024-2030
... the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills ... Read More
-
Tuberculosis (TB) Diagnostics Industry Research Report 2024
... Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Opportunities and Forecast to 2030
... other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about ... Read More
-
Strand Displacement Amplification Market Size, Trends, Analysis, and Outlook By Application (Tuberculosis, Hepatitis, Malaria, Influenza, Cancer, Others), By End-User (Hospitals, Diagnostic laboratories, Others), by Country, Segment, and Companies, 2024-2032
... size is poised to register 5.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Strand Displacement Amplification market across By Application (Tuberculosis, ... Read More
-
Infectious Disease Drugs Market Size, Trends, Analysis, and Outlook By Disease (HIV, Influenza, Hepatitis, Tuberculosis, Malaria, Others), By Treatment (Antibacterial, Antiviral, Antiparasitic, Others), by Country, Segment, and Companies, 2024-2032
... size is poised to register 7.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Infectious Disease Drugs market across By Disease (HIV, ... Read More
-
Diagnostic Specialty Antibodies Market Size, Trends, Analysis, and Outlook By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), By Application (Hepatitis, Tuberculosis, Dengue, Oncology, HIV, Infectious Disease, Others), By End-User (Hospitals, Diagnostic Laboratories, Others), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Diagnostic Specialty Antibodies market size is poised to register 4.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Live Attenuated Vaccines Market - By Vaccine Type (Bacterial, Viral), Development (Tissue Culture, Embryonated Eggs, Live Animals), Age Group, Mode of Administration, Indication (Tuberculosis, Measles, Rotavirus), End-use - Global Forecast (2024 Â 2032)
... vaccines market will witness 10.4% CAGR from 2024 to 2032. The long-term protection provided by live vaccines against diseases has led to their widespread use besides their ability to stimulate a strong immune response, further ... Read More
-
Tuberculosis - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Tuberculosis Understanding ... Read More
-
Infectious Vaccines Market Size, Trends, Analysis, and Outlook By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others), By Disease(Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Vaccines market size is poised to register 6.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Infectious Respiratory Disease Diagnostics Market Size, Trends, Analysis, and Outlook By Product (Instruments, Consumables, Services), By Sample Type (Saliva, Nasopharyngeal Swabs (NPS), Anterior Nasal Region, Blood, Others), By Application (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Tuberculosis, Streptococcus Testing, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By End-User (Hospitals, Diagnostic Laboratories, Physician Offices, Others), by Region, Country, Segment, and Companies, 2024-2030
... Tuberculosis, Streptococcus Testing, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By End-User (Hospitals, Diagnostic Laboratories, Physician Offices, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Respiratory Disease Diagnostics market size is ... Read More
-
Latent Tuberculosis Infection Detection Market Size, Trends, Analysis, and Outlook By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)), By Application (Household Contacts with Pulmonary TB, PLHIV, Others), By End-user (Diagnostic Laboratories, Hospitals/clinics, Academic & Research Institutions), by Region, Country, Segment, and Companies, 2024-2030
... Hospitals/clinics, Academic & Research Institutions), by Region, Country, Segment, and Companies, 2024-2030 The global Latent Tuberculosis Infection Detection market size is poised to register 5.72% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
-
Tuberculosis Therapeutics Market Size, Trends, Analysis, and Outlook By Disease (Active TB, Latent TB), By Therapy (First-Line Therapy, Second-Line Therapy), By Route of Administration (Oral, Parenteral, Others), By Dosage Form (Tablets, Capsules, Injection, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Tuberculosis Therapeutics market size is poised to register 5.24% growth from 2024 to 2030, presenting significant growth prospects ... Read More
-
Zoonotic Disease Treatment Market Size, Trends, Analysis, and Outlook By Type (Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Others), By Causative Agent (Bacteria, Virus, Nematode, Rodents, Ticks, Others), By Drug Class (Anti-fungal, Anti-bacterial, Antibiotics, Others), By Route of Administration (Oral, Topical, Others), By End-user (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... By Route of Administration (Oral, Topical, Others), By End-user (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Zoonotic Disease ... Read More
-
Computer-Aided Detection Market Size, Trends, Analysis, and Outlook By Application (Tuberculosis, Breast cancer, Lung cancer, Colon/rectal cancer, Prostate cancer, Liver cancer, Bone cancer, Neurological/musculoskeletal/cardiovascular Indications), By Indication (X-ray imaging, Computed tomography, Ultrasound imaging, Magnetic resonance imaging, Nuclear medicing imaging, Others), by Region, Country, Segment, and Companies, 2024-2030
... imaging, Nuclear medicing imaging, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Computer-Aided Detection market size is poised to register 6.57% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Infectious Disease Molecular Diagnostics Market Size, Trends, Analysis, and Outlook By Product & Service (Reagents, Kits, Consumables, Instruments, Software & Services), By Type of Testing (Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample Type (Blood, Serum, and Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample ... Read More
-
BCG Vaccine Market Size, Trends, Analysis, and Outlook By Product (Immune BCG, Therapy BCG), By Age Group (Paediatrics, Adults), By Application (Tuberculosis, Bladder Cancer), By Distribution Channel (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global BCG Vaccine market size is poised to register 6.77% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global BCG ... Read More
-
Bovine Tuberculosis Diagnosis Market Size, Trends, Analysis, and Outlook By Test Type (Serological Tests, Molecular Diagnostic Tests, Traditional Tests), by Region, Country, Segment, and Companies, 2024-2030
... to register 4.8% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Bovine Tuberculosis Diagnosis market across By Test Type (Serological Tests, Molecular ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Testing Chest X-Rays
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Treatment Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
